Regeneron Pharmaceuticals Inc (REGN)

Industry Biotechnology
This stock can be held in an Investment ISA and an Investment Account
Sell

$590.50

Buy

$595.00

arrow-up$9.33 (+1.59%)

Regeneron Pharmaceuticals Inc is an integrated biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.
Prices updated at 17 May 2025, 00:59 EDT
| Prices minimum 15 mins delay
|
Prices in USD
NASDAQ
arrow-up0.52%
NASDAQ
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.
Sector
Healthcare
Industry
Biotechnology
Chairman
Dr. George D. Yancopoulos,M.D.,PhD
CEO
Dr. Leonard S. Schleifer,M.D.,PhD
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
15,158
Head office
777 Old Saw Mill River Road
Tarrytown
United States
10591-6707
mobile
+1 914 847-7000
letter
manisha.narasimhan@regeneron.com
computer
Company website

Key personnel

Owner nameSalaryBonusAll other compensationTotal compensationRestricted stock award
Mr. Arthur Frederick Ryan
Independent Director
0.12m--0.72m-
Dr. Leonard S. Schleifer,M.D.,PhD
Co-Chairman of the Board, Co-President and Chief Executive Officer
1.94m--6.82m-
Dr. Joseph L. Goldstein,M.D.
Independent Director
0.11m--0.71m-
Dr. N. Anthony Coles, M.D.
Independent Director
0.10m--0.70m-
Dr. Michael S. Brown, M.D.
Independent Director
0.12m--0.72m-
Dr. Craig B. Thompson,M.D.
Independent Director
0.10m--0.70m-
Ms. Christine A. Poon
Lead Independent Director
0.17m--0.77m-
Dr. George D. Yancopoulos,M.D.,PhD
Co-Chairman of the Board, Co-President and Chief Scientific Officer
1.94m--6.80m-
Mr. George L. Sing
Independent Director
0.12m--0.72m-
Mr. Joseph J. Larosa
Executive Vice President, General Counsel and Secretary
-----
Mr. Daniel P. Van Plew
Executive Vice President and General Manager, Industrial Operations and Product Supply
0.96m--8.66m-
Dr. David P. Schenkein, M.D.
Independent Director
0.10m--0.29m-
Dr. Bonnie L. Bassler, PhD
Independent Director
0.11m--0.71m-
Ms. Marion McCourt
Executive Vice President, Commercial
-----
Dr. Huda Y. Zoghbi, M.D.
Independent Director
0.11m--0.71m-
Mr. Christopher R. Fenimore
Executive Vice President, Finance and Chief Financial Officer
0.66m--6.27m-
Mr. Andrew J Murphy
Executive Vice President, Research
0.80m--8.36m-
Ms. Kathryn Guarini, PhD
Independent Director
0.10m--0.29m-
Mr. Jason Pitofsky
Principal Accounting Officer, Vice President and Controller
-----

Top 5 shareholders

Owner nameNo. of sharesShare as % of port.Last changePortfolio % changeDate of portfolio% Total assets
Vanguard Group Inc9,407,8910.107881215451.30885730 Apr 20258.71
BlackRock Inc8,925,8800.11891942582.22476430 Apr 20258.27
FMR Inc7,598,5840.30768-600995-7.32958430 Apr 20257.04
Fidelity Management and Research Company7,598,5840.30768-600995-7.32958430 Apr 20257.04
Fidelity Management & Research Company LLC7,324,36824.02268-439709-30 Apr 20256.78

Director dealings

DateActionNamePriceValueNo. of sharesHolding (%)Additional info
31 Dec 2024-Mr. George L. Sing413.331,379,69629,610--
02 Jan 2025-Mr. George L. Sing--1,958--
31 Dec 2024-Mr. George L. Sing-----
02 Jan 2025-Mr. George L. Sing--27,828--
31 Dec 2024-Mr. George L. Sing708.191,379,55427,662--
16 Dec 2024-Dr. Neil Stahl,PhD730.81222,16648,829--
16 Dec 2024-Mr. Joseph J. Larosa730.81513,02930,075--
16 Dec 2024-Mr. Daniel P. Van Plew730.81708,15534,792--
16 Dec 2024-Ms. Marion McCourt730.81554,68514,230--
16 Dec 2024-Mr. Christopher R. Fenimore730.81358,82816,265--
16 Dec 2024-Mr. Andrew J Murphy730.81770,27449,074--
16 Dec 2024-Mr. Jason Pitofsky730.81217,7814,664--
09 Dec 2024-Dr. Neil Stahl,PhD787.00366,74249,133--
06 Dec 2024-Mr. Joseph J. Larosa--31,269--
09 Dec 2024-Mr. Joseph J. Larosa787.00387,20430,777--
06 Dec 2024-Mr. Joseph J. Larosa--8,981--
06 Dec 2024-Mr. Daniel P. Van Plew--13,472--
09 Dec 2024-Mr. Daniel P. Van Plew787.00387,20435,761--
06 Dec 2024-Mr. Daniel P. Van Plew--36,253--
06 Dec 2024-Ms. Marion McCourt--8,981--
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.